Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells
Authors
Keywords
-
Journal
Biomed Research International
Volume 2019, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2019-11-07
DOI
10.1155/2019/2560650
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
- (2018) You-Cai Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The functional interplay between the HIF pathway and the ubiquitin system – more than a one-way road
- (2017) Julia Günter et al. EXPERIMENTAL CELL RESEARCH
- Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis
- (2017) Alexandra Giatromanolaki et al. EXPERIMENTAL LUNG RESEARCH
- Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
- (2017) Fubo Zhou et al. MEDICINAL RESEARCH REVIEWS
- Biology and function of glypican-3 as a candidate for early cancerous transformation of hepatocytes in hepatocellular carcinoma
- (2017) Mauro Montalbano et al. ONCOLOGY REPORTS
- Glypican 3 as a Serum Marker for Hepatoblastoma
- (2017) Shengmei Zhou et al. Scientific Reports
- Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection
- (2016) Zainen Qin et al. MACROMOLECULAR BIOSCIENCE
- Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
- (2016) F Graziano et al. PHARMACOGENOMICS JOURNAL
- Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
- (2016) Run-Ze Shang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
- (2015) Zhaoyong Li et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
- (2015) Li Wang et al. Hepatobiliary & Pancreatic Diseases International
- Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway
- (2015) YONGLE WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
- (2015) Rupert Courtnay et al. MOLECULAR BIOLOGY REPORTS
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma
- (2015) Morgane Sanzey et al. PLoS One
- Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma
- (2014) J. G. Sham et al. JOURNAL OF NUCLEAR MEDICINE
- c-Myc and Cancer Metabolism
- (2012) D. M. Miller et al. CLINICAL CANCER RESEARCH
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Plasma Metabolomics and Lipid Profiling
- (2011) A. D. Patterson et al. CANCER RESEARCH
- Choosing between glycolysis and oxidative phosphorylation: A tumor's dilemma?
- (2010) Caroline Jose et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
- (2008) R. Ventura-Clapier et al. CARDIOVASCULAR RESEARCH
- Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer
- (2008) S. J. Yeung et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now